The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
An update on larynx cancer
Open accessAbstract
Answer questions and earn CME/CNE Laryngeal cancer remains one of the most common tumors of the respiratory tract. Fortunately, significant advancements have been made over the past decade in the treatment of laryngeal cancer. Although surgery has been the historical mainstay for localized disease and still is an integral part of treatment, nonsurgical options like radiation and systemic therapy have emerged as viable options. In addition, in the metastatic setting, novel agents are showing promise for this patient population. The care for patients with laryngeal cancer continues to evolve and truly requires a multidisciplinary team‐based approach. Unique morbidities, such as loss of natural voice, respiration, and airway protection during swallowing, are observed with this disease and require special consideration. CA Cancer J Clin 2017;67:31–50. © 2016 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21332 · Cited by 16,003
Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer
Borghaei, H., Paz-Ares, L., Horn, L., Spigel, D. R., Steins, M., Ready, N. E., Chow, L. Q., Vokes, E. E., Felip, E., Holgado, E., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1507643 · Cited by 9,335
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
Larkin, J., Chiarion-Sileni, V., Gonzalez, R., Grob, J. J., Cowey, C. L., Lao, C. D., Schadendorf, D., Dummer, R., Smylie, M., Rutkowski, P., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504030 · Cited by 8,157
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
Bonner, J. A., Harari, P. M., Giralt, J., Azarnia, N., Shin, D. M., Cohen, R. B., Jones, C. U., Sur, R., Raben, D., Jassem, J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053422 · Cited by 5,115
Comprehensive genomic characterization of head and neck squamous cell carcinomas
The Cancer Genome Atlas Network (2015) · Nature · doi:10.1038/nature14129 · Cited by 3,877
Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer
Vermorken, J. B., Mesia, R., Rivera, F., Remenar, E., Kawecki, A., Rottey, S., Erfan, J., Zabolotnyy, D., Kienzer, H.-R., Cupissol, D., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802656 · Cited by 3,726
Concurrent Chemotherapy and Radiotherapy for Organ Preservation in Advanced Laryngeal Cancer
Forastiere, A. A., Goepfert, H., Maor, M., Pajak, T. F., Weber, R., Morrison, W., Glisson, B., Trotti, A., Ridge, J. A., Chao, C., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa031317 · Cited by 3,174
Pignon, J.-P., Maître, A. L., Maillard, E., & Bourhis, J. (2009) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2009.04.014 · Cited by 3,069
(1991) · New England Journal of Medicine · doi:10.1056/nejm199106133242402 · Cited by 2,733
Bernier, J., Cooper, J. S., Pajak, T. F., van Glabbeke, M., Bourhis, J., Forastiere, A., Ozsahin, E. M., Jacobs, J. R., Jassem, J., Ang, K.-K., et al. (2005) · Head & Neck · doi:10.1002/hed.20279 · Cited by 1,772
Seiwert, T. Y., Burtness, B., Mehra, R., Weiss, J., Berger, R., Eder, J. P., Heath, K., McClanahan, T., Lunceford, J., Gause, C., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30066-3 · Cited by 1,745 · cited 1×
“A response rate of 18% was reported in this heavily pretreated population, with a median PFS of 2 months and a median OS of 13 months.(129) Pembrolizumab has recently been approved by the US Food and Drug Administration for platinum-refractory, metastatic SCCHN.”
BackgroundCisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer
Vermorken, J. B., Remenar, E., van Herpen, C., Gorlia, T., Mesia, R., Degardin, M., Stewart, J. S., Jelic, S., Betka, J., Preiss, J. H., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa071028 · Cited by 1,719
Nutting, C. M., Morden, J. P., Harrington, K. J., Urbano, T. G., Bhide, S. A., Clark, C., Miles, E. A., Miah, A. B., Newbold, K., Tanay, M., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70290-4 · Cited by 1,706
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
Posner, M. R., Hershock, D. M., Blajman, C. R., Mickiewicz, E., Winquist, E., Gorbounova, V., Tjulandin, S., Shin, D. M., Cullen, K., Ervin, T. J., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa070956 · Cited by 1,705
Machtay, M., Moughan, J., Trotti, A., Garden, A. S., Weber, R. S., Cooper, J. S., Forastiere, A., & Ang, K. K. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.8841 · Cited by 1,371
Lefebvre, J.-L., Chevalier, D., Luboinski, B., Kirkpatrick, A., Collette, L., & Sahmoud, T. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.13.890 · Cited by 1,334
Forastiere, A. A., Zhang, Q., Weber, R. S., Maor, M. H., Goepfert, H., Pajak, T. F., Morrison, W., Glisson, B., Trotti, A., Ridge, J. A., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.43.6097 · Cited by 1,296
Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis
Bourhis, J., Overgaard, J., Audry, H., Ang, K. K., Saunders, M., Bernier, J., Horiot, J.-C., Le Maître, A., Pajak, T. F., Poulsen, M. G., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69121-6 · Cited by 1,085
Vermorken, J. B., Trigo, J., Hitt, R., Koralewski, P., Diaz-Rubio, E., Rolland, F., Knecht, R., Amellal, N., Schueler, A., & Baselga, J. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.7447 · Cited by 1,009
Boffetta, P., & Hashibe, M. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70577-0 · Cited by 877
Laryngeal Cancer in the United States: Changes in Demographics, Patterns of Care, and Survival
Hoffman, H. T., Porter, K., Karnell, L. H., Cooper, J. S., Weber, R. S., Langer, C. J., Ang, K., Gay, G., Stewart, A., & Robinson, R. A. (2006) · The Laryngoscope · doi:10.1097/01.mlg.0000236095.97947.26 · Cited by 846
Ang, K. K., Zhang, Q., Rosenthal, D. I., Nguyen-Tan, P. F., Sherman, E. J., Weber, R. S., Galvin, J. M., Bonner, J. A., Harris, J., El-Naggar, A. K., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.5633 · Cited by 838
Haddad, R., O'Neill, A., Rabinowits, G., Tishler, R., Khuri, F., Adkins, D., Clark, J., Sarlis, N., Lorch, J., Beitler, J. J., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70011-1 · Cited by 750
Ndiaye, C., Mena, M., Alemany, L., Arbyn, M., Castellsagué, X., Laporte, L., Bosch, F. X., de Sanjosé, S., & Trottier, H. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70471-1 · Cited by 722
Speech and Survival: Tradeoffs between Quality and Quantity of Life in Laryngeal Cancer
McNeil, B. J., Weichselbaum, R., & Pauker, S. G. (1981) · New England Journal of Medicine · doi:10.1056/nejm198110223051704 · Cited by 677
Immunology and Immunotherapy of Head and Neck Cancer
Ferris, R. L. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.1509 · Cited by 668
Jacobs, C., Lyman, G., Velez-García, E., Sridhar, K. S., Knight, W., Hochster, H., Goodnough, L. T., Mortimer, J. E., Einhorn, L. H., & Schacter, L. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.2.257 · Cited by 628
Blanchard, P., Baujat, B., Holostenco, V., Bourredjem, A., Baey, C., Bourhis, J., & Pignon, J.-P. (2011) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2011.05.036 · Cited by 621
Cohen, E. E. W., Karrison, T. G., Kocherginsky, M., Mueller, J., Egan, R., Huang, C. H., Brockstein, B. E., Agulnik, M. B., Mittal, B. B., Yunus, F., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.6309 · Cited by 571
Cancer Statistics for African Americans
Ghafoor, A., Jemal, A., Cokkinides, V., Cardinez, C., Murray, T., Samuels, A., & Thun, M. J. (2002) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.52.6.326 · Cited by 549
Remacle, M., Eckel, H. E., Antonelli, A., Brasnu, D., Chevalier, D., Friedrich, G., Olofsson, J., Rudert, H. H., Thumfart, W., de Vincentiis, M., et al. (2000) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s004050050228 · Cited by 525
Why the Epidermal Growth Factor Receptor? The Rationale for Cancer Therapy
Baselga, J. (2002) · The Oncologist · doi:10.1634/theoncologist.7-2004-2 · Cited by 510
Gibson, M. K., Li, Y., Murphy, B., Hussain, M. H. A., DeConti, R. C., Ensley, J., & Forastiere, A. A. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.057 · Cited by 496
Chung, C. H., Zhang, Q., Kong, C. S., Harris, J., Fertig, E. J., Harari, P. M., Wang, D., Redmond, K. P., Shenouda, G., Trotti, A., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.5228 · Cited by 374
Current Treatment Options for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Sacco, A. G., & Cohen, E. E. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.62.0963 · Cited by 343
Cancer statistics for African Americans, 2013
DeSantis, C., Naishadham, D., & Jemal, A. (2013) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21173 · Cited by 291
Tobacco use and cancer causation: association by tumour type
Kuper, H., Boffetta, P., & Adami, H. ‐. (2002) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2002.01022.x · Cited by 284
Laryngeal Cancer: Diagnosis and Preoperative Work-up
Chu, E. A., & Kim, Y. J. (2008) · Otolaryngologic Clinics of North America · doi:10.1016/j.otc.2008.01.016 · Cited by 258
Hammerlid, E., Ahlner-Elmqvist, M., Bjordal, K., Biörklund, A., Evensen, J., Boysen, M., Jannert, M., Kaasa, S., Sullivan, M., & Westin, T. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690420 · Cited by 239
Magrini, S. M., Buglione, M., Corvò, R., Pirtoli, L., Paiar, F., Ponticelli, P., Petrucci, A., Bacigalupo, A., Crociani, M., Lastrucci, L., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.1671 · Cited by 214
Impact of radiotherapy dose on dentition breakdown in head and neck cancer patients
Walker, M. P., Wichman, B., Cheng, A.-L., Coster, J., & Williams, K. B. (2011) · Practical Radiation Oncology · doi:10.1016/j.prro.2011.03.003 · Cited by 178
Vargo, J. A., Ferris, R. L., Ohr, J. P., et al. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2014.11.023 · Cited by 156
Health status and voice outcome after treatment for T1a glottic carcinoma
Peeters, A. J. G. E., van Gogh, C. D. L., Holtzer-Goor, K., Leeuw, I. M. V., Langendijk, J. A., & Mahieu, H. F. (2004) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-003-0697-5 · Cited by 119
ASBESTOS AND LARYNGEAL CARCINOMA
Stell, P. M. (1973) · The Lancet · doi:10.1016/s0140-6736(73)92275-7 · Cited by 118
Postlaryngectomy Voice Rehabilitation: State of the Art at the Millennium
Brown, D. H., Hilgers, F. J. M., Irish, J. C., & Balm, A. J. M. (2003) · World Journal of Surgery · doi:10.1007/s00268-003-7107-4 · Cited by 115
Groome, P. A., O’Sullivan, B., Irish, J. C., Rothwell, D. M., Schulze, K. M., Warde, P. R., Schneider, K. M., Mackenzie, R. G., Hodson, D. I., Hammond, J. A., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.10.106 · Cited by 111
Hinerman, R. W., Mendenhall, W. M., Amdur, R. J., et al. (2002) · Head & Neck · doi:10.1002/hed.10069 · Cited by 111
Nutritional surveillance and weight loss in head and neck cancer patients
Ehrsson, Y. T., Langius‐Eklöf, A., & Laurell, G. F. E. (2011) · Supportive Care in Cancer · doi:10.1007/s00520-011-1146-4 · Cited by 101
Occupational Exposures and Cancer of the Larynx—Systematic Review and Meta-analysis
Paget‐Bailly, S., Cyr, D., & Luce, D. (2011) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0b013e31823c1343 · Cited by 98
Cancer of the larynx in non-smoking alcohol drinkers and in non-drinking tobacco smokers
Bosetti, C., Gallus, S., Franceschi, S., Levi, F., Bertuzzi, M., Negri, E., Talamini, R., & Vecchia, C. L. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600469 · Cited by 89
The quality of life of patients following treatment for laryngeal cancer
Harwood, A. R., & Rawlinson, E. (1983) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(83)90292-4 · Cited by 82
Gama, R. R., Carvalho, A. L., Longatto‐Filho, A., Scorsato, A. P., López, R. V. M., Rautava, J., Syrjänen, S., & Syrjänen, K. J. (2015) · The Laryngoscope · doi:10.1002/lary.25738 · Cited by 80
Wang, D., Qian, G., Zhang, H., Magliocca, K. R., Nannapaneni, S., Amin, A. R. M. R., Rossi, M., Patel, M. R., El‐Deiry, M. W., Wadsworth, J. T., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0558 · Cited by 72
Self-citationDiet diversity and the risk of laryngeal cancer: A case–control study from Italy and Switzerland
Garavello, W., Lucenteforte, E., Bosetti, C., Talamini, R., Levi, F., Tavani, A., Franceschi, S., Negri, E., & Vecchia, C. L. (2008) · Oral Oncology · doi:10.1016/j.oraloncology.2008.02.011 · Cited by 66
Finizia, C. A., & Bergman, B. (2001) · The Laryngoscope · doi:10.1097/00005537-200105000-00031 · Cited by 65
Jiang, N., Wang, D., Hu, Z., Shin, H. J. C., Qian, G., Rahman, M. A., Zhang, H., Amin, A. R. M. R., Nannapaneni, S., Wang, X., et al. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-1093 · Cited by 61
Self-citationGillison, M. L., Blumenschein, G. R., Fayette, J., et al. (2016) · Cancer Research · doi:10.1158/1538-7445.am2016-ct099 · Cited by 36
ABCLOVE: Voice therapy outcomes for patients with head and neck cancer
Ouyoung, L. M., Swanson, M. S., Villegas, B. C., Damodar, D. M., Kokot, N., & Sinha, U. K. (2015) · Head & Neck · doi:10.1002/hed.24322 · Cited by 20
Cited by
Mody, M. D., Rocco, J. W., Yom, S. S., Haddad, R. I., & Saba, N. F. (2021) · The Lancet · doi:10.1016/s0140-6736(21)01550-6 · Cited by 847
Self-citationUpdates on larynx cancer epidemiology
Nocini, R., Section of Ear Nose and Throat (ENT), D. O. S. S., Molteni, G., Mattiuzzi, C., Lippi, G., Service of Clinical Governance, P. A. F. S. A. S. S., & Section of Clinical Biochemistry, D. O. N. (2020) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2020.01.03 · Cited by 283
Biological Function of Long Non-coding RNA (LncRNA) Xist
Wang, W., Min, L., Qiu, X., Wu, X., Liu, C., Ma, J., Zhang, D., & Zhu, L. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.645647 · Cited by 248
Artificial Intelligence and Laryngeal Cancer: From screening to prognosis: A state of the art review
Bensoussan, Y., Vanstrum, E. B., Johns, M. M., & Rameau, A. (2023) · Otolaryngology–Head and Neck Surgery · doi:10.1177/01945998221110839 · Cited by 44
Kwon, I., Wang, S.-G., Shin, S.-C., Cheon, Y.-I., Lee, B.-J., Lee, J.-C., Lim, D.-W., Jo, C., Cho, Y., & Shin, B.-J. (2025) · Journal of Voice · doi:10.1016/j.jvoice.2022.07.007 · Cited by 43
Metadata
- Authors
- Steuer, C. E., El‐Deiry, M., Parks, J. R., Higgins, K. A., & Saba, N. F.
- Venue
- CA: A Cancer Journal for Clinicians
- Publisher
- Wiley
- Published
- 2016-11-29
- Volume
- 67
- Issue
- 1
- Pages
- 31-50
- ISSN
- 0007-9235 (ISSN-L)
- 1542-4863
- OpenAlex
- W2557888310
- Cited by
- 672
- References
- 58
- FWCI
- 22.76
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.